Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism (2006)
- Autores:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.lfs.2006.01.034
- Assuntos: FARMACOLOGIA; HEMODINÂMICA (EFEITOS); EMBOLIA; HIPERTENSÃO
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Life Sciences
- ISSN: 0024-3205
- Volume/Número/Paginação/Ano: v. 79, p. 469-474, 2006
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DIAS-JÚNIOR, Carlos A. e TANUS-SANTOS, José Eduardo. Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. Life Sciences, v. 79, p. 469-474, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2006.01.034. Acesso em: 16 abr. 2024. -
APA
Dias-Júnior, C. A., & Tanus-Santos, J. E. (2006). Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. Life Sciences, 79, 469-474. doi:10.1016/j.lfs.2006.01.034 -
NLM
Dias-Júnior CA, Tanus-Santos JE. Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism [Internet]. Life Sciences. 2006 ; 79 469-474.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.lfs.2006.01.034 -
Vancouver
Dias-Júnior CA, Tanus-Santos JE. Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism [Internet]. Life Sciences. 2006 ; 79 469-474.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.lfs.2006.01.034 - Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Hemodynamic effects of bupropion in anesthetized dogs
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
- Estudo de associação de haplótipos da Enos e insuficiência renal crônica
Informações sobre o DOI: 10.1016/j.lfs.2006.01.034 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
